Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
616.00    -8.00 (-1.28%)
Bid:
615.00
Ask:
620.00
Spread: 5.00 (0.813%)
Market Cap: £536.69m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

AGM and Interim Management Statement

7 Feb 2012 07:00

RNS Number : 8868W
Victrex PLC
07 February 2012
 



For Stock Exchange release at 7.00 a.m. Tuesday 7 February 2012

 

Victrex plc

  

AGM and Interim Management Statement

 

At the Annual General Meeting of Victrex plc to be held today, Chairman Anita Frew will make the following statement which comprises Victrex's Interim Management Statement covering the period from 1 October 2011 to date:

  

"We are pleased to announce that, following the de-stocking reported in our Victrex Polymer Solutions business ('VPS') in Q1 of our financial year, Group sales volume for January came back strongly at 288 tonnes (2011: 265 tonnes). This brings the four month total Group sales volume to 870 tonnes.

 

We remain mindful of the continuing economic uncertainty and the impact it may have on VPS sales volume for the full year. However, the current order book for February and new business development activity are encouraging.

 

Our Invibio Biomaterial Solutions business has made a solid start to the financial period and we continue to expect growth for the year.

 

There have been no significant changes in the financial position of the Company since 30 September 2011 and the Group remains in an excellent financial position with a healthy balance sheet and strong cash generation.

 

Our capacity expansion plans are on track and we continue to invest in new application development and technical leadership to ensure we capitalise on the growth potential for our business."

 

 

 

 

Victrex will host a conference call at 8.00 a.m. today for analysts. If you would like more details, please contact Naomi Lane at MHP on 0203 128 8204 / Naomi.Lane@mhpc.com.

 

The Group will also hold an investor day for institutional investors and analysts in London tomorrow, Wednesday 8 February, focusing on its VPS division. No new trading or price sensitive information will be disclosed. A copy of the presentation will be made available on Victrex's website following the event.

 

Victrex will provide a trading update for the six months to 31 March 2012 on Thursday 5 April 2012.

 

 

Enquiries

 

Victrex plc

Anita Frew, Chairman 0203 128 8100 (7 February 2012)

David Hummel, Chief Executive 01253 897700 (thereafter)

Steve Barrow, Finance Director

 

MHP Communications

Nick Denton / Barnaby Fry / Ian Payne 0203 128 8100

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a provider of innovative, high performance thermoplastic polymers. We work with customers and end users globally to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions business unit ('VPS') focuses on our transport, industrial and electronics markets and our Invibio® Biomaterial Solutions business unit ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMDMGGZKVGGZZM
Date   Source Headline
17th Jun 202111:29 amRNSDirector/PDMR Shareholding
16th Jun 20212:13 pmRNSAdditional Listing
2nd Jun 202111:10 amRNSDirector/PDMR Shareholding
1st Jun 20219:35 amRNSBlock listing Interim Review
28th May 20211:09 pmRNSTotal Voting Rights
18th May 20214:50 pmRNSDirector Declaration
18th May 202110:32 amRNSDirector/PDMR Shareholding
17th May 202110:56 amRNSDirector/PDMR Shareholding
13th May 202110:08 amRNSAdditional Listing
10th May 20217:00 amRNSVictrex plc Interim Results
30th Apr 20212:41 pmRNSTotal Voting Rights
19th Apr 20212:37 pmRNSDirector/PDMR Shareholding
16th Apr 202110:36 amRNSDirector Declaration
9th Apr 202111:00 amRNSAdditional Listing
31st Mar 20211:52 pmRNSTotal Voting Rights
17th Mar 20211:41 pmRNSDirector/PDMR Shareholding
1st Mar 202111:37 amRNSDirector/PDMR Shareholding
26th Feb 20211:47 pmRNSTotal Voting Rights
17th Feb 202110:32 amRNSDirector/PDMR Shareholding
12th Feb 20211:53 pmRNSResult of AGM
12th Feb 20217:00 amRNSAGM and Q1 Interim Management Statement
10th Feb 20212:37 pmRNSDirector/PDMR Shareholding
29th Jan 20212:33 pmRNSTotal Voting Rights
19th Jan 20213:50 pmRNSDirector/PDMR Shareholding
7th Jan 20212:06 pmRNSAnnual Report and Accounts
6th Jan 20212:34 pmRNSDirector/PDMR Shareholding
31st Dec 20209:00 amRNSTotal Voting Rights
17th Dec 20203:09 pmRNSDirector/PDMR Shareholding
15th Dec 202012:57 pmRNSDirector/PDMR Shareholding
11th Dec 20202:47 pmRNSDirector/PDMR Shareholding
9th Dec 20207:00 amRNSVictrex plc – Preliminary Results 2020
1st Dec 202010:59 amRNSBlock listing Interim Review
30th Nov 202011:24 amRNSTotal Voting Rights
17th Nov 20209:49 amRNSDirector/PDMR Shareholding
30th Oct 202011:40 amRNSTotal Voting Rights
19th Oct 202011:34 amRNSDirector/PDMR Shareholding
14th Oct 202012:17 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSVictrex plc Full Year Trading Statement
30th Sep 20209:30 amRNSTotal Voting Rights
29th Sep 20204:09 pmRNSHolding(s) in Company
17th Sep 202011:00 amRNSDirector/PDMR Shareholding
28th Aug 20209:56 amRNSTotal Voting Rights
19th Aug 202011:01 amRNSDirector/PDMR Shareholding
31st Jul 202011:53 amRNSTotal Voting Rights
20th Jul 202010:45 amRNSDirector/PDMR Shareholding
17th Jul 20204:43 pmRNSDirector/PDMR Shareholding
8th Jul 20207:00 amRNSVictrex Q3 Interim Management Statement
30th Jun 202011:30 amRNSTotal Voting Rights
17th Jun 202011:44 amRNSDirector/PDMR Shareholding
15th Jun 20204:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.